Evotec AG has formed a multi-year compound management agreement with Pierre Fabre Laboratories, a French pharmaceutical company under which Evotec will manage Pierre Fabre’s compound collection (individual compounds and collection plates) out of its compound management facility in Toulouse, France. The agreement covers an initial period of five years.

Evotec, based in Hamburg, Germany, provides drug discovery and development services.

Source: Evotec